Missense mutations have been identified in the coding region of the extracellular calcium-sensing receptor (CASR) gene and cause human autosomal dominant hypo-and hypercalcemic disorders. The functional effects of several of these mutations have been characterized in either Xenopus laevis oocytes or in human embryonic kidney (HEK293) cells. All of the mutations that have been examined to date, however, cause single putative amino acid substitutions. In this report, we studied a mutant CASR with an Alu-repetitive element inserted at codon 876, which was identified in affected members of families with the hypercalcemic disorders, familial hypocalciuric hypercalcemia ( 
Introduction
Familial hypocalciuric hypercalcemia ([FHH] 1 also known as familial benign hypercalcemia) is an autosomal dominant condition characterized by modest elevation in serum calcium concentration, relative hypocalciuria, and inappropriately normal (i.e., nonsuppressed) parathyroid hormone (PTH) levels (1-3). However, affected individuals exhibit virtually none of the usual morbidity associated with hypercalcemia. Neonatal severe hyperparathyroidism ([NSHPT] also termed neonatal familial primary hyperparathyroidism), on the other hand, is a disorder characterized by marked elevation in serum calcium and PTH levels, skeletal demineralization, and parathyroid cellular hyperplasia that can be lethal without parathyroidectomy (4, 5) . Despite the disparate clinical features of these conditions, the coexistence of NSHPT and FHH in some families suggested a relationship between these two disorders (6) (7) (8) . Identification of inactivating mutations in the extracellular calcium (Ca 2 ϩ o )-sensing receptor (CASR) (9, 10) located in chromosome region 3q13.3-21 (11) , revealed molecular interrelationships between FHH and NSHPT (12, 13) . That is, individuals with FHH are heterozygous, and some cases of NSHPT are homozygous for such mutations (also see references [14] [15] [16] [17] .
The wild-type human CASR is a G protein-coupled receptor predicted to be 1,078 amino acids in length. Stimulation of the receptor by polycationic agonists, such as Ca o . The primary actions of PTH on kidney and bone are to raise serum calcium levels by increasing reabsorption of calcium in the former and resorption of calcium and phosphate in the latter, thereby elevating Ca 2 ϩ o (18) . The identification of mutations in the CASR in FHH and NSHPT strongly supports the concept that the receptor is a key element in mediating the physiological responses of the parathyroid gland to alterations in Ca 2 ϩ o . The receptor was also localized in kidney with a lower abundance. It has been hypothesized that the CASR acts as an antagonist to PTH action on renal Ca 2 ϩ handling (19) . That is, activation of the receptor directly reduces calcium reabsorption in the distal tubule. When the activity of the receptor is reduced by inactivating mutations, in turn, a higher than normal level of Ca 2 ϩ o is required to achieve a given degree of suppression of PTH release from the parathyroid gland and enhancement of calcium excretion by the kidney, consistent with the phenotype of "resistance" to Ca 2 ϩ o observed in FHH and NSHPT. Recent functional characterization of some mutated CASRs that had been identified in patients with FHH or NSHPT revealed that mutations could interfere with ( a ) posttranslational modification of the CASR by N -glycosylation with more complex carbohydrates; ( b ) sensitivity of the CASR to ligands; and/or ( c ) activation of associated G protein (20, 21) . We recently documented the insertion of a complete Alu repetitive element at codon 876 in the intracellular domain of the CASR in both FHH and NSHPT (17) . The Alu repeat is in the opposite orientation to the CASR gene and contains an exceptionally long poly(A/T) tract of between 92 and 94 bp. The insertion is predicted to yield a truncated protein of 910-961 amino acids in length, with loss of the normal CASR sequence of 877-1078 amino acids (see Fig. 1 ). The first 876 amino acids of the CASR would be tailed by the unrelated sequence, QLTLS, and a stretch of 29 phenylalanine residues encoded by the poly(U) tract. Then depending upon the reading frame, the mutant CASR protein terminates at either amino acid 910, 946, or 961.
In this report, we have expressed the full-length receptor containing the Alu insertion in HEK293 cells and determined its ( a ) pattern of protein expression, ( b ) responses to CASR agonists (e.g., Ca 
Methods
Clinical and genetic studies. Consent was obtained from all participants or their guardians in accordance with local institutional guidelines. The three families (D, Qu, and S) with affected FHH and NSHPT members harboring the Alu insertion have been described previously (5, 13, 17, 22, 23) . Measurement of serum total calcium concentration was carried out by colorimetric assay, and measurement of serum ionized calcium was performed using a Nova 7 Analyzer (Nova Biomedical, Waltham, MA). DNA was extracted from peripheral lymphocytes as described previously (24) . For one affected member of each family the presence of the Alu insertion in exon 7 of the CASR was demonstrated by PCR analysis of genomic DNA as described previously (17) , and in all other family members the presence of the mutation was tested for by Southern blot analysis of AvaII-digested genomic DNA using a [ 32 P]-labeled CASR-exon 7 probe. In vitro transcription and translation of partial CASR coding region containing the Alu insertion. Nucleotides ϩ 1804 to ϩ 3333 encoding the CASR mRNA ( ϩ 1 is the first nucleotide of the AUG initiation codon and ϩ 3237 is the last nucleotide of the TAA stop codon) were PCR-amplified from genomic DNA from either unaffected or NSHPT individuals using the primers shown in Table I . Forward primer, PTT-F(T7), which was used if the PCR product was directly transcribed without subcloning, was modified at its 5 Ј end by addition of a T7 promoter and consensus eukaryotic translation initiation sequence. Forward primer, PTT-F, was used if the PCR product was subcloned first, before transcription, and, in all cases, reverse primer, PTT-R, was used. 500 ng genomic DNA were used as template in 50-l reactions containing PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% [wt/vol] gelatin), 200 M of each deoxynucleotide, 50 pmol of each primer, and 0.5 units Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT). PCR conditions were as follows: 5 min at 98 Њ C, followed by 30 cycles of 45 s at 94 Њ C, 2.5 min at 62 Њ C, 1 min at 72 Њ C, and a final elongation step at 72 Њ C for 10 min, using the GeneAmp PCR System Thermocycler 9600 (Perkin-Elmer Cetus Corp.). A deletion mutant was created lacking the long poly(A/T) tract in the Alu repetitive sequence by generating overlapping PCR products using primers PTT-F and DEL-R, and DEL-F and PTT-R (Table I ). The final recombinant was generated by amplifying the two products with PTT-F and PTT-R. PCR conditions were as described above. The PCR products were subcloned into the pCR2.1 TA cloning vector (Invitrogen Corp., San Diego, CA) and selected for an ap- The normal CASR protein sequence stops at amino acid 876 and is followed by the sequence Gln-Leu-Thr-Leu-Ser and 29 Phe residues encoded by the poly(U) tract. Then depending on the reading frame, the mutant CASR will terminate at amino acid 910, 946, or 961. The two larger predicted mutant proteins differ in size from the smallest by ‫ف‬ 4 and ‫ف‬ 6 kD, respectively.
propriate orientation downstream of the T7 promoter. The plasmid DNAs were linearized at the 3 Ј end of the coding sequence by XbaI digestion. Sense strand RNAs were generated with T7 RNA polymerase (Promega Corp., Madison, WI) as described by Melton et al. (25) . The RNA concentrations were determined by OD 260 . In vitro transcribed products were analyzed on a denaturing formaldehyde gel in 0.1 M Mops (pH 7.0) running buffer. 1 g of each RNA was used as a template for protein synthesis in a rabbit reticulocyte lysate in vitro translation system (Promega Corp.) in the presence of [ Cloning of the Alu insert into the full-length wild-type receptor. A PCR product with the Alu insertion at amino acid 876 was obtained using primers 7BF and 7BR as described (17) and cloned into the pCRII TA cloning vector (Invitrogen Corp.). The plasmid was doubly digested with SphI and BamHI, and its B-fragment was cloned into cassette VI of the reconstructed human CASR cDNA (20) . Then the cassette VI carrying the Alu insertion was doubly digested with XhoI and XbaI and cloned into the wild-type reconstructed receptor in pcDNA3 (20) .
Site-directed mutagenesis. Site-directed mutagenesis to produce a receptor truncated at amino acid position 876 was performed using the approach described by Kunkel (20, 26) . The dut-1 ung-1 strain of Escherichia coli , CJ236, was transformed with mutagenesis cassette 6 as described by Bai et al. (20) . Uracil-containing, single stranded (ss) DNA was produced by infecting the cells with the helper phage, VCSM13. The ssDNA was then annealed to a mutagenesis primer (MUT1; see Table I ) that contained the desired nucleotide change encoding a single point mutation (in this case introduction of a stop codon) flanked on both sides by wild-type sequence. The primer was then extended around the entire ssDNA and ligated to generate closed circular heteroduplex DNA. DH5 ␣ competent cells were transformed with the heteroduplex DNA, and incorporation of the desired mutation was confirmed by sequencing the entire cassette.
Transient expression of the wild-type receptor and the mutated receptor carrying the Alu insertion in HEK293 cells. The DNA for transfection was prepared using the Midi Plasmid Kit (Qiagen Inc., Chatsworth, CA), and Lipofectamine (Gibco-BRL, Gaithersburg, MD) was used as a DNA carrier for transfection (27) . The HEK293 cells used for transient transfection were provided by NPS Pharmaceuticals, Inc. (Salt Lake City, UT) and were cultured in DMEM (Gibco-BRL) with 10% FBS (Hyclone, Logan, VT). The DNA-liposome complex was prepared by mixing DNA and lipofectamine in Opti-MEM I reduced serum medium (Gibco-BRL) and incubating the mixture at room temperature for 30 min. The DNA-lipofectamine mixture was then diluted with Opti-MEM I reduced serum medium and added to 90% confluent HEK293 cells plated on 13.5 ϫ 20.1-mm glass cover slips using 0.625 or 2.5 g of DNA (for measurement of Ca 2 ϩ i ) or in 100-mm petri dishes using 3.75 or 15 g of DNA (for obtaining crude membrane protein for Western analysis). After 5 h incubation at 37 Њ C, equivalent amounts of Opti-MEM I reduced serum medium with 20% FBS were added to the medium overlying the transfected cells, and the latter was replaced with fresh DMEM with 10% FBS at 24 h after the transfection. The expressed CASR protein was assayed 48 h after the start of transfection (essentially identical Ca 2 ϩ i doseresponse curves were obtained when either 0.625 or 2.5 g of DNA were transfected [reference 20]). To perform coexpression of wildtype and mutant receptors, 0.625 g each of wild-type and the mutant receptor cDNAs were mixed and used to transfect HEK293 cells as described above.
Tunicamycin treatment of transiently transfected HEK293 cells. Tunicamycin (5 g/ml) (Boehringer-Mannhein Biochemicals, Indianapolis, IN) was added to HEK293 cells 5 h after transfection with the mutant receptor to block N -glycosylation of the newly synthesized receptor protein (28) . The cells were then incubated for 48 h before harvesting of plasma membranes for Western analysis of the CASR as described below.
Crude plasma membrane preparation. Crude plasma membranes were isolated from HEK293 cells transiently transfected with rHuPCaR4.0 (10) or the mutant receptor by differential speed centrifugation as described by Sun et al. (29) . Confluent cultured cells in 100-mm culture plates were rinsed twice with PBS and treated with 0.02% EDTA in PBS at 37 Њ C for 5 min. The detached cells were pelleted and resuspended in 300 l of homogenization buffer: 50 mM TrisHCl, pH 7.4, containing 0.32 M sucrose, 1 mM EDTA, and protease inhibitors (including 83 g/ml aprotonin, 30 g/ml leupeptin, 1 g/ml pefabloc, 50 g/ml calpain inhibitor, 50 g/ml bestatin, 5 g/ml pepstatin, and 1 mM EDTA). Then the cells were homogenized with 15 strokes of a motor-driven Teflon pestle in a tightly fitting glass tube. The homogenate was sedimented at 18,800 g for 20 min to remove nuclei and mitochondria. The supernatant was subsequently sedimented at 43,500 g for 20 min to pellet the plasma membranes, and the resultant pellet was solubilized with 1% Triton X-100. All steps were carried out at 4 Њ C.
Western analysis of plasma membrane proteins. After determination of the protein concentration in the crude plasma membrane 
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*T7 promoter and eukaryotic initiation sequence is bolded in PTT-F(T7). Complementary sequence to the TAA stop codon is bolded in MUT1.
preparations using the Pierce BCA protein assay (Pierce, Rockford, IL), an appropriate amount of membrane protein (4 g) was subjected to SDS-PAGE (30) using a linear gradient of polyacrylamide (4-12%). The proteins on the gel were subsequently electrotransferred to a nitrocellulose membrane. After blocking with 5% milk, the blot was incubated either with an antibody (4641; kindly provided by Drs. Forrest Fuller and Richel Simin, NPS Pharmaceuticals, Inc., Salt Lake City, UT), which is specific for the CASR (20) , or the anti-FLAG M2 Monoclonal antibody. The CASR protein was detected using a peroxidase-coupled secondary antibody with an ECL system (Amersham Corp.).
Measurement of Ca 2ϩ
i by fluorimetry in cell populations. Coverslips coated with HEK293 cells that had been transfected with wildtype and/or mutant CASR cDNAs were loaded for 2 h at room temperature with fura-2/AM in 20 mM Hepes, pH 7.4, containing 125 mM NaCl, 4 mM KCl, 0.5 mM CaCl 2 , 0.5 mM MgCl 2 , 0.1% dextrose and 0.1% BSA) at 37ЊC for 20 min. The coverslips were then placed diagonally in a thermostatted quartz cuvette containing standard medium, using a modification of techniques employed previously (31) . CASR agonists were added to give the desired final concentrations. Excitation monochrometers were centered at 340 and 380 nm with emission light collected at 510Ϯ40 nm through a wide-band emission filter. The 340/380 excitation ratio of emitted light was used to calculate Ca 2ϩ i as described previously (31 (20) which precedes the insertion position was amplified using the primer pair, M13 (20) and FLAG-R (Table I) , and a fragment following the insertion position was amplified using the primer pair FLAG-F and T3 (Table I ). The two PCR products were gel-purified, mixed with 1 l of 10 mM dNTP, 5 l of 10ϫ reaction buffer (Promega Corp.), 3.75 l of 25 mM MgCl 2 and 5 U of Taq polymerase in a total volume of 50 l, and fused. The following conditions were used for fusion: 4.5 min at 94ЊC for 1 cycle; followed by 30 s at 94ЊC, 30 s at 65ЊC, and 50 s at 72ЊC for 20 cycles; finally, 5 min at 72ЊC. The fused DNA was further amplified using M13 (20) and T3. The FLAG epitope, YKDDDDK, was inserted into the CASR between D371 and T372 by subcloning the final PCR product into rHuPCaR4.0 through the NheI and AflII sites (20) . The insertion was confirmed by sequencing.
Determination of cell surface expression by immunocytochemistry. Cells on coverslips transfected with FLAG-tagged CASR or the wild-type, untagged CASR were first fixed with 4% formaldehyde in PBS for 5 min at room temperature. Endogenous peroxidases were then inhibited by incubating the cells in Dako Peroxidase Blocking Reagent (Dako Corp., Santa Barbara, CA) for 10 min, and the cells were further treated with Dako Protein Block Serum-Free solution (Dako Corp.) for 1 h (11, 12) . Cells were then incubated overnight at 4°C with anti-FLAG M2 monoclonal antibody (VWR Scientific, Bridgeport, NJ). The final concentration of antibody was 10 g/ml.
After washing the cells three times with 0.5% BSA in PBS, for 20 min each, a peroxidase-coupled, sheep anti-mouse IgG, diluted 1:100 (Sigma Chemical Co., St. Louis, MO), was added and incubated for 1 h at room temperature. The cells were then washed with PBS three times, for 20 min each, and stained with the Dako AEC Substrate System (Dako Corp.) for ‫ف‬ 5 min. The color reaction was stopped by washing three times with water. The stained coverslips were mounted on slides with AQUA-MOUNT (Lerner Laboratories, Pittsburgh, PA). Photomicrographs were taken with a ϫ63 objective.
Results

Serum total and ionized calcium in affected FHH family members.
The affected FHH patients had mean (ϮSD) serum total and ionized calcium concentrations of 2.58Ϯ0.09 mM/ 10.32Ϯ0.36 mg/dl (n ϭ 10) and 1.33Ϯ0.05 mM/5.32Ϯ0.2 mg/dl (n ϭ 10), respectively, which are slightly higher than those of unaffected family members, that is, 2.27Ϯ0.06 mM/9.08Ϯ0.24 mg/dl (n ϭ 4) and 1.16Ϯ0.06 mM/4.64Ϯ0.24 mg/dl (n ϭ 4), respectively, (significant differences: P Ͻ 0.0001, total calcium; P Ͻ 0.0002, ionized calcium).
Use of a modified PTT to assess the consequence of the Alu insertion. Fig. 2 shows a schematic diagram of the assay indicating the possible RNA and protein products and their predicted sizes. In vitro transcription revealed that the wild-type receptor cDNA yielded a single transcript of 1.5 kb, whereas the mutant yielded 1.9 and 0.9 kb products present in approximately equal amounts (Fig. 3 A) . Subsequent in vitro translation then gave a single product for wild-type with a molecular mass of 50 kD, close to that predicted on the basis of the nucleotide sequence (53 kD), while in vitro translation of the mutant gave rise to three products with molecular weights of 36, 34, and 30 kD (Fig. 3 B) . These are all ‫ف‬ 4 kD less than the three predicted species of 910, 946, and 961 amino acids (see Fig. 1 ). However, the anomalous migration of proteins with unusual amino acid compositions on polyacrylamide gels is well known (34, 35) , and the observed result is consistent with the presence of the long hydrophobic/polyphenylalanine tract in all three mutant products. Similar results were obtained either by directly analyzing PCR-amplified genomic DNA or after subcloning the DNA. Deletion of the long (A/T) tract from the Alu mutant led to the elimination of the smaller, arrested transcript, but translation of the poly (A/T) deleted mutant still yielded three protein products (data not shown).
Western analysis of the CASR containing the Alu insertion mutation. The expressed receptor containing the Alu insertion, like the wild-type receptor, showed three immunoreactive bands, but the sizes of these bands for the mutant receptor were substantially reduced compared to those for the wild-type CASR (Fig. 4) . Even the high molecular mass species observed for the wild-type receptor ‫ف(‬ 350 kD) were also reduced in size. The estimated molecular mass of the nonglycosylated form(s) of the mutated receptor was ‫ف‬ 90 kD (range 85-91 kD), ‫ف‬ 30 kD smaller than that of the wild-type receptor ‫ف(‬ 120 kD) (20) .
Effect of inhibition of glycosylation of the mutant CASR with tunicamycin. Crude plasma membranes were isolated from HEK293 cells transiently transfected with the mutant CASR and incubated in the presence or absence (control) of tunicamycin for 48 h. The doublet between 140 and 97 kD present in untreated cells was completely absent in cells treated with tunicamycin and was replaced by a series of bands at ‫ف‬ 90 kD (range 86-91 kD), which is present in the untreated cells but at a much lower level (Fig. 4) . Ca Coexpression of the wild-type receptor with the Alu insertion mutant receptor. The mutant receptor did not interfere with the function of the coexpressed wild-type receptor (Fig. 5) . The Ca 2ϩ o dose-response curve of the coexpressed receptors was essentially superimposable on that of the wild-type receptor alone.
Western analysis of the CASR containing the Alu insertion mutation and a truncated mutant CASR (A877 stop).
Although the mutant receptor with the Alu insertion is predicted to have at least 34 amino acids unrelated to CASR protein after T876 (the position of the Alu insertion), the mutant has an apparent molecular mass on SDS-PAGE similar to the receptor truncated after T876 (Fig. 6) . A similar anomolous migration on SDS-PAGE was noted above for protein fragments obtained from in vitro translation of Alu-containing PCR products which had estimated sizes smaller than their predicted molecular masses (see Fig. 3 ). This is most probably due to the polyphenylalanine tract encoded by the long poly (A/T) sequence of the Alu insertion. Interestingly, the expression level of the truncated mutant at A877 is substantially higher than that of the wildtype receptor.
Characterization of FLAG-tagged wild-type receptor. To facilitate immunocytochemical analysis of wild-type and mutant receptors on the cell surface, we created a CASR containing the FLAG epitope within the extracellular domain (see Methods). The FLAG-tagged wild-type receptor is similar to the wild-type nontagged receptor in terms of its Ca (Fig. 7) , and the levels of protein expression for the two receptors determined by Western analysis of crude membrane preparations and staining with antireceptor antibody, Figure 6 . Western analysis of wild-type and mutant CASR. Crude plasma membrane proteins were isolated from HEK293 cells (grown in 100-mm petri dishes) that were transiently transfected with 3.75 g of the wild-type rHuPCaR4.0, the mutant receptor with Alu insertion or the truncated receptor (A877stop). The crude plasma membrane protein samples, 4 g each, were subjected to SDS-PAGE on a linear gradient running gel of 4-12%. Western analysis of the FLAG-tagged rHuPCaR4.0. Crude plasma membrane proteins were isolated from HEK293 cells (grown in 100-mm petri dishes) which were transiently transfected with 3.75 g of the wild-type rHuPCaR4.0 or FLAG-tagged rHuPCaR4.0. The crude plasma membrane protein samples, 4 g each, were subjected to SDS-PAGE on a linear gradient running gel of 4-12%. In both A and B, lane 1: rHuPCaR4.0; lane 2: FLAG-tagged rHuPCaR4.0. In A, the CASR proteins were stained with antireceptor antibody, 4641, as described in Methods. In B, the FLAG-tagged rHuPCaR4.0 was stained with anti-FLAG M2 monoclonal antibody. Fig. 8 A) are also similar. The specificity of staining with the anti-FLAG M2 monoclonal antibody is demonstrated in Fig. 8 B.
(
Determination of cell surface expression of the FLAGtagged receptors using immunocytochemistry. As shown in Fig. 9 B, HEK293 cells transfected with the FLAG-tagged wild-type receptor have strong staining with anti-FLAG M2 monoclonal antibody which is not present in cells transfected with the wild-type receptor without the tag (Fig. 9 A) . The rimlike staining of the cells expressing the wild-type receptor is characteristic of the cell surface expression of the receptor. Such staining is much reduced in the cells transfected with the mutant receptor with the Alu insertion (Fig. 9 C) . In contrast, cells transfected with the truncated mutant receptor (A877 stop) (Fig. 9 D) have much more pronounced rim-like staining than that of the wild-type receptor consistent with its higher level of expression as assessed by Western analysis (Fig. 6 ).
Discussion
Alu-repetitive elements are detected predominantly within introns or the 5Ј-and 3Ј-noncoding regions of genes. The presence of an Alu sequence in a coding region is an extremely rare event (36, 37) and the functional consequences of such an insertion have not been studied previously. The Alu-repetitive element in the FHH kindreds studied here is in the opposite orientation to the CASR gene and contains an exceptionally long poly(A/T) tract. The mutated receptor is predicted to have the NH 2 -terminal wild-type sequence up to amino acid 876 and to be terminated at a stop codon positioned after a stretch of unrelated sequence, Gln-Leu-Thr-Leu-Ser and 29 phenylalanines, all of which are derived from the Alu insertion. In vitro transcription and translation of the mutant receptor gene resulted in three protein products corresponding to termination of translation after amino acids 910, 946, and 961 as predicted (see Fig. 1 ). This finding most likely relates to the expansion and contraction during transcription of the length of the polyuridine tracts encoded by this Alu sequence. Poly(A/T) tracts are well known to encourage frameshift mutagenesis and slippage during replication by DNA polymerases (38) and transcription by RNA polymerases (39) . With reference to DNA replication it has been documented previously that the poly(A/T) tracts of Alu sequences are polymorphic (40-42). There are two stretches of poly(A/T) within the Alu repeat of the CASR. One corresponds to the extremely long poly(A) tail and the other to the A-rich region typically found between the right and left monomers (43) . When we deleted the long poly (A/T) tract, slippage during transcription/translation was still apparent indicating that other sequences, probably the shorter A/T-rich region, were also contributing to the frame-shift mutagenesis. It has been hypothesized (44) that antisense Alu elements found within exons are not translated, because of their complementarity to 7SL RNA, a component of the signal recognition particle. It was speculated that the RNA would hybridize with the antisense Alu sequence, thereby inhibiting the elongation process. Our data is inconsistent with this hypothesis and demonstrates that the Alu-directed frameshift mutagenesis affected the process of mRNA translation in a qualitative manner leading to the production of three related mutant proteins differing only in their COOH-terminal tails. Importantly, it is likely this was occurring not only in the in vitro PTT assay, but also in the HEK293 cells transfected with the Alu mutant construct, in which closely sized proteins, ranging from 86-91 kD, were apparent on Western analysis using the CASR antibody in the crude plasma membrane preparation (see Fig. 4,  lane 3) . A transcriptional effect of the Alu was also apparent in vitro, and we noted the generation of a shorter transcript representing up to 50% of the full-length mutant transcript. The size of the shorter transcript was consistent with truncation occurring just at the beginning of the long poly(A/T) tract, a known "arrest site" for RNA polymerases (45, 46) . In addition, deletion of the poly(A/T) tract abolished the generation of the shorter transcript.
The mutant receptor shows a qualitatively similar expression pattern and levels of the corresponding receptor species by Western analysis were similar to those of wild-type receptor albeit with proportionally reduced sizes. Thus, the insertion does not interfere with the stability of the truncated receptor protein that was translated from the mRNA harboring it. Therefore, the Alu insertion may cause inactivation of the receptor by impairing its signal transduction capabilities, as we also demonstrated with a mutant CASR truncated at the site of the Alu insertion, through loss of the majority of its COOHterminal intracellular domain which can be important for G protein coupling (47) . Also, much reduced cell-surface expression of the mutant receptor was demonstrated indicating a further deleterious effect of the additional missense sequence in retarding the trafficking of the mutant receptor to the cell surface. In contrast, the overall expression of the CASR (A877 stop) mutant was markedly increased relative to that of wildtype CASR, and this was reflected in its greater cell surface expression. At present little is known of the potential for desensitization of the CASR which may occur in a similar fashion to that shown for other G protein-coupled receptors. This occurs by rapid uncoupling of the receptor from its G protein(s), subsequent sequestration of the receptor from the plasma membrane, and internalization followed by proteolytic degradation (48) . Our data points to a potentially important role of the COOH-terminal domain in mediating the normal internalization and degradation of the CASR.
The mutant Alu insertion receptor also did not interfere with the normal function of the coexpressed wild-type receptor in HEK293 cells, in agreement with the observation that heterozygotes (i.e., with FHH) with one mutated and one normal allele in these three kindreds have very mild elevations in serum calcium (2.58 mM) versus unaffected individuals (2.27 mM). This is analogous to the situation in an animal model in which mice heterozygous for targeted disruption of the CASR gene manifest only a slight increase in serum calcium concentration (49) . This emphasizes the important role of gene dosage in determining the level of CASR protein on the parathyroid cell surface. In contrast, individuals homozygous for the Alu insertion mutation (i.e., with NSHPT) have very severe elevations of both serum calcium as well as PTH (13, 23) due to the total absence of functional CASRs.
In summary, we report a functional analysis of a naturally occurring mutation that deletes much of the COOH-terminal region of the CASR. Further structure-function studies of this region of the CASR will lead to a more precise understanding of the requirements for receptor/G protein-coupling and desensitization of the receptor. In addition, our studies provide novel insights into the way in which insertion of a repetitive element into a protein-coding exon can disrupt gene expression.
